These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19652463)
21. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland. Zhang R; Haag JD; Gould MN Cell Growth Differ; 1991 Jan; 2(1):1-6. PubMed ID: 2007094 [TBL] [Abstract][Full Text] [Related]
22. Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development-possible application for a model to detect co-modifiers of carcinogenesis. Imai T; Cho YM; Hasumura M; Hirose M Cancer Lett; 2005 Dec; 230(1):25-32. PubMed ID: 16253758 [TBL] [Abstract][Full Text] [Related]
23. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527 [TBL] [Abstract][Full Text] [Related]
24. Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor. Chou YC; Guzman RC; Swanson SM; Yang J; Lui HM; Wu V; Nandi S Carcinogenesis; 1999 Apr; 20(4):677-84. PubMed ID: 10223199 [TBL] [Abstract][Full Text] [Related]
25. Frequent c-Ha-ras gene mutations in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Hokaiwado N; Asamoto M; Cho YM; Imaida K; Shirai T Cancer Lett; 2001 Feb; 163(2):187-90. PubMed ID: 11165753 [TBL] [Abstract][Full Text] [Related]
26. Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis. Lu SJ; Archer MC Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1001-5. PubMed ID: 1736280 [TBL] [Abstract][Full Text] [Related]
27. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566 [TBL] [Abstract][Full Text] [Related]
28. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice. Guzman RC; Osborn RC; Swanson SM; Sakthivel R; Hwang SI; Miyamoto S; Nandi S Cancer Res; 1992 Oct; 52(20):5732-7. PubMed ID: 1394197 [TBL] [Abstract][Full Text] [Related]
29. Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Thompson HJ; Adlakha H; Singh M Carcinogenesis; 1992 Sep; 13(9):1535-9. PubMed ID: 1394836 [TBL] [Abstract][Full Text] [Related]
30. Absence of H-ras point mutation at codon 12 in N-methyl-N-nitrosourea-induced hepatocellular neoplasms in the rat. Li H; Lee GH; Cui LX; Liu J; Nomura K; Ohtake K; Kitagawa T J Cancer Res Clin Oncol; 1990; 116(4):331-5. PubMed ID: 1975252 [TBL] [Abstract][Full Text] [Related]
31. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats. Thompson TA; Haag JD; Gould MN Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551 [TBL] [Abstract][Full Text] [Related]
32. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. Cha RS; Guerra L; Thilly WG; Zarbl H Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072 [TBL] [Abstract][Full Text] [Related]
33. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. McCormick DL; Adamowski CB; Fiks A; Moon RC Cancer Res; 1981 May; 41(5):1690-4. PubMed ID: 7214338 [TBL] [Abstract][Full Text] [Related]
34. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Zhang R; Haag JD; Gould MN Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653 [TBL] [Abstract][Full Text] [Related]
35. Dietary effects of conjugated docosahexaenoic acid on N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats. Danbara N; Uehara N; Shikata N; Takada H; Hada T; Tsubura A Oncol Rep; 2004 Nov; 12(5):1079-85. PubMed ID: 15492796 [TBL] [Abstract][Full Text] [Related]
36. Formation and repair of O6-methylguanine and methylation of the Ha-ras proto-oncogene by N-methyl-N-nitrosourea are not associated with mammary tumor resistance in the Copenhagen rat. Lu SJ; Chaulk EJ; Archer MC Carcinogenesis; 1992 May; 13(5):857-61. PubMed ID: 1586999 [TBL] [Abstract][Full Text] [Related]
37. Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats. Shimano N; Uehara N; Kiyozuka Y; Shikata N; Tsubura A In Vivo; 2007; 21(6):983-8. PubMed ID: 18210745 [TBL] [Abstract][Full Text] [Related]
38. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats. Lu SJ; Archer MC Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917 [TBL] [Abstract][Full Text] [Related]
39. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model. Hal DG; Stoica G Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]